In an in vivo competitive assay, KO or Tg CD45.2+CD8+ T cells were mixed at a 1:1 ratio with their corresponding control CD8+ T cells carrying a congenic marker CD45.1+, which were subsequently transferred into B16 tumor-bearing recipient mice. Here, CD8A is linked to neoplasm.